✦ LIBER ✦

Case Report: Fatal Exacerbation of Hepatitis C-Related Cryoglobulinemia with Interferon-alpha Therapy

✍ Scribed by Gad Friedman; Shailesh Mehta; Averell H. Sherker

Book ID: 111567419
Publisher: Springer US
Year: 1999
Tongue: English
Weight: 58 KB
Volume: 44
Category: Article
ISSN: 0163-2116
DOI: 10.1023/a:1026691416498

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Suspected acute exacerbation of idiopath

Suspected acute exacerbation of idiopathic pulmonary fibrosis associated with interferon alpha therapy for hepatitis C: case report

✍ Victoria Yee-May Ling, Marianne Mortimore, David J Serisier 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 542 KB

Long-term results of therapy with interf

Long-term results of therapy with interferon alpha for cryoglobulinemia associated with hepatitis C virus infection

✍ J. M. Durand; E. Cretel; G. Kaplanski; P. Lefevre; F. Retornaz; J. Soubeyrand 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 273 KB

Severe exacerbation of hepatitis C–assoc

Severe exacerbation of hepatitis C–associated vasculitic neuropathy following treatment with interferon alpha: A case report and literature review

✍ Kanokwan Boonyapisit; Bashar Katirji 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Induction and exacerbation of psoriasis

Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: A review and analysis of 36 cases

✍ M. Afshar; A.D. Martinez; R.L. Gallo; T.R. Hata 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB

Treatment of hepatitis C related thrombo

Treatment of hepatitis C related thrombocytopenia with interferon alpha

✍ Sandeep Rajan; Howard A. Liebman 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

Therapy of hepatitis C: Re-treatment wit

Therapy of hepatitis C: Re-treatment with alpha interferon

✍ A Alberti; L Chemello; F Noventa; L Cavalletto; GianLuca De Salvo 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

The long-term benefit of interferon therapy in chronic hepatitis C is limited. During therapy, serum alanine aminotransferase (ALT) levels decrease to normal and hepatitis C virus (HCV) RNA decreases in 40% to 60% of patients. However, most patients relapse after therapy withdrawal, so that no more